206679 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-12-01 |
| Register Year | 2022 |
| Product Type | Human |
| Drug Type | Biological |
| Scientific Name | ONASEMNOGENE ABEPARVOVEC |
| Trade Name | Zolgensma |
| Strength Unit | vg/ml |
| Pharmaceutical Form | Suspension for injection |
| Administration Route | Intravenous use |
| Atc Code1 | M09AX |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Vial |
| Package Size | 9 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $7984675.9 |
| Shelf Life | 12 Months |
| Marketing Company | Novartis Gene Therapies EU limited |
| Marketing Country | Ireland |
| Manufacture Name | Novartis Gene Therapies, Inc |
| Manufacture Country | United States |
| Secondry package manufacture | |
| Main Agent | Novartis Saudi Limited |
| Secosnd Agent | |
| Third Agent | |
| Visits | 206679 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| Zolgensma | $7984675.9 | 206679 visits | 2022-12-01 |